Search results
Results from the WOW.Com Content Network
The study analyzed data from over 88,000 people with dementia and over 880,000 control participants who were dementia-free. Researchers found that taking certain commonly prescribed drugs for 5 ...
A GABA reuptake inhibitor (GRI) is a type of drug which acts as a reuptake inhibitor for the neurotransmitter gamma-Aminobutyric acid (GABA) by blocking the action of the gamma-Aminobutyric acid transporters (GATs). This in turn leads to increased extracellular concentrations of GABA and therefore an increase in GABAergic neurotransmission. [1]
Additional research and support resources from the Alzheimer’s Association can be found at www.alz.org. Original article source: 5 major Alzheimer’s discoveries scientists made in 2024 Show ...
Take it easy with alcohol. Research finds that so-called "heavy" drinkers are more likely to develop dementia than "moderate" ones. But there's good news: Even dropping your drinking levels from ...
[36] [37] [38] Although the term "GABA С receptor" is frequently used, GABA С may be viewed as a variant within the GABA A receptor family. [7] Others have argued that the differences between GABA С and GABA A receptors are large enough to justify maintaining the distinction between these two subclasses of GABA receptors.
Mirtazapine, sold under the brand name Remeron among others, is an atypical tetracyclic antidepressant, and as such is used primarily to treat depression. [11] [12] Its effects may take up to four weeks but can also manifest as early as one to two weeks.
Dementia is a complicated condition, and researchers are still unpacking a lot about its underlying causes. However, there are some things doctors generally agree on when it comes to prevention ...
A GABA analogue is a compound which is an analogue or derivative of the neurotransmitter gamma-Aminobutyric acid (GABA) (the IUPAC of which is 4-aminobutanoic acid). Many GABA analogues are used as drugs , especially as anticonvulsants , sedatives , and anxiolytics .